The Benefits and Risks of Smokeless Tobacco Products

Sep.06.2022
The Benefits and Risks of Smokeless Tobacco Products
Phillip Morris promotes non-combustible products as a safer alternative to smoking, backed by scientific evidence.

Smokers understand that smoking is harmful. However, data shows that most people are unaware that the primary issue with smoking is the smoke itself. When a cigarette is lit, it reaches high temperatures and the smoke produced from burning tobacco contains approximately 6,000 chemical compounds.


Approximately 100 substances have been identified by recognized public health authorities as harmful or potentially harmful. The high levels of these chemicals in cigarette smoke are the primary cause of smoking-related illnesses.


Innovation choice.


Innovative alternatives that eliminate combustion can release nicotine without producing smoke or ashes. While these products are still easily addictive and not without risks, they have the potential to significantly reduce the average levels of harmful chemicals compared to traditional cigarettes.


An independent study conducted by PMI has shown that 43% of respondents are confused by smoke-free products they have seen, read about or heard about. However, 76% of smokers would consider switching to less harmful alternatives if more information was available.


A woman snapped a cigarette in half. Source: PIXABAY new regulations.


In recent years, the market has seen an influx of new types of tobacco and nicotine products. Advances in technology and science have made it possible to develop smoke-free options, which while not without risk, may be a safer alternative for adult smokers who would otherwise continue to smoke traditional cigarettes.


More and more countries have implemented regulations on the use and distribution of alternative tobacco products that differ from traditional cigarettes. This allows adult smokers to transition to these product categories instead of continuing to smoke. Examples of such countries include the United States, Sweden, Japan, and the United Kingdom, which have also established very strict regulations on the use of traditional cigarettes.


Heating, non-burning products and non-flammable products do not produce smoke, which actually carries harmful substances that can cause tobacco-related diseases.


These products heat tobacco without burning it, significantly reducing the production of harmful chemicals. This innovative technology is backed by scientific evidence and marketing that differentiates and regulates such products can help adult smokers who would otherwise continue to smoke traditional cigarettes to switch to these alternatives and reduce their exposure to harmful chemicals.


The Power of Nicotine


Nicotine naturally occurs in tobacco leaves. This is one of the reasons why people smoke, besides factors such as taste and ritual. However, nicotine is not without risks, and can be addictive. Nevertheless, the primary cause of smoking-related diseases is the smoke, not the nicotine itself.


There are nine million smokers in Spain.


How do we address the over 1.3 billion smokers worldwide, with almost 9 million in Spain? Adult smokers who will continue to smoke should be treated in such a way that they are provided with accurate information based on scientific evidence, allowing them to make informed decisions.


Tar


One of the most harmful elements in cigarette smoke is known as "tar," which is not the same as the substance used for paving roads as some people mistakenly believe. Tar is a term used to refer to the thousands of chemicals released in cigarette smoke.


Two options


The best choice for adult smokers is to completely quit the use of tobacco and/or nicotine products.


However, as mentioned above, many of them will continue to smoke, which is the most harmful form of tobacco use.


In this situation, an increasing number of health authorities are recommending smoke-free products as a better choice for these consumers.


There are essentially two categories of products:


Electronic cigarettes use the energy from batteries to heat liquid containing nicotine and produce vapor, hence the term "vape". Additionally, they contain other substances such as propylene glycol, glycerin, flavorings, and other additives.


Heating tobacco products, used in conjunction with electronic devices, heats the tobacco without burning it, creating an aerosol instead of smoke.


Fake news.


According to the Unsmoke 2020 study conducted in collaboration with independent advisors Bovado and Phillip Morris, the smoking population in Spain is a victim of certain misconceptions about these products, and is unaware that non-combustible alternatives can help reduce smoking.


Half of the survey respondents indicated that the information they receive about e-cigarettes or heated tobacco products is contradictory or unclear. Meanwhile, 72% of those surveyed believe that authorities should allocate resources towards achieving the goal of providing scientifically verified new alternatives to help people quit smoking.


If they had more information about the differences between these alternative products and traditional cigarettes, even eight out of ten people would consider switching to them.


Philip Morris' bet


In summary, studies have confirmed that harmful substances generated from the burning of tobacco and cigarette smoke are the main causes of tobacco-related illnesses. For this reason, Philip Morris is committed to gradually replacing cigarettes with innovative smoke-free products.


Philip Morris is leading the paradigm shift in the industry, having spent over a decade researching and developing verified alternatives to traditional cigarettes. Since then, the company has been dedicated to developing and studying innovative non-combustible products that may be less harmful than traditional cigarettes.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The compilation of this article is intended for industry exchange and research purposes.


Due to limitations in translation ability, the translated article may not fully express the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, and foreign-related statements and positions.


The copyrights of the compiled information belong to the original media and authors. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands has agreed to acquire 100% of Swedish modern oral nicotine company Yoik Group AB for an initial SEK515 million, equivalent to about US$53.9 million, plus a deferred payment linked to performance over the next two years. Yoik owns nicotine pouch brand Helwit, which held about 3.4% of Sweden’s modern oral nicotine market over the past 12 months. Imperial says the acquisition will more than double its existing share of the Swedish market. Helwit is also sold elsewhere in the Nordics, through European online channels and in selected UK retail outlets.
Sep.08
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI nicotine pouch brand Nordic Spirit has entered a long-term partnership with Manchester’s Co-op Live, becoming the venue’s Official Nicotine Pouch Partner. The 23,500-capacity venue is the UK’s largest indoor live entertainment arena. Nordic Spirit will run in-venue activations for existing adult nicotine consumers and sell products at selected arena bars. The agreement was entered into before the relevant UK sponsorship restrictions were introduced, while the government intends to implement a comprehensive ban on advertising and sponsorship of vaping and nicotine products from June 1, 2027.
Sep.07
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26